{"entity":{"type":"insider","cik":"0001816977","url":"/insider/0001816977","json_url":"/insider/0001816977.json","name":"Pons Jaume","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":47,"n_filings":21,"first":"2021-03-24","last":"2025-02-21","span_basis":"filed_date"},"name_variants":[{"name":"Pons Jaume","source":"filing","n_filings":21,"first_seen":"2021-03-24","last_seen":"2025-02-21"}],"transactions":[{"id":4174920,"accession":"0001415889-25-005069","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-005069","line_url":"/filing/0001415889-25-005069#line-1","is_derivative":false,"issuer_cik":"0001810182","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001810182","owner_cik":"0001816977","owner_name":"Pons Jaume","owner_display_name":"Pons Jaume","owner_url":"/insider/0001816977","role":"Officer (PRESIDENT & CSO)","role_mark":"O","role_mark_label":"Officer (PRESIDENT & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1326.0,"shares_display":"1,326","price_per_share":1.1502,"price_display":"1.15","price_state":"stated","total_value":1525.1652,"total_display":"1,525.17","total_whole":"1,525","shares_owned_after":579388.0,"shares_owned_after_display":"579,388","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-19","filed_date":"2025-02-21","scope":"insider"},{"id":4280472,"accession":"0001415889-25-000123","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-000123","line_url":"/filing/0001415889-25-000123#line-1","is_derivative":false,"issuer_cik":"0001810182","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001810182","owner_cik":"0001816977","owner_name":"Pons Jaume","owner_display_name":"Pons Jaume","owner_url":"/insider/0001816977","role":"Officer (PRESIDENT & CSO)","role_mark":"O","role_mark_label":"Officer (PRESIDENT & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10796.0,"shares_display":"10,796","price_per_share":1.5802,"price_display":"1.58","price_state":"stated","total_value":17059.8392,"total_display":"17,059.84","total_whole":"17,060","shares_owned_after":580714.0,"shares_owned_after_display":"580,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-30","filed_date":"2025-01-02","scope":"insider"},{"id":2900356,"accession":"0001415889-24-021474","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-021474","line_url":"/filing/0001415889-24-021474#line-1","is_derivative":false,"issuer_cik":"0001810182","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001810182","owner_cik":"0001816977","owner_name":"Pons Jaume","owner_display_name":"Pons Jaume","owner_url":"/insider/0001816977","role":"Officer (PRESIDENT & CSO)","role_mark":"O","role_mark_label":"Officer (PRESIDENT & CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1937.0,"shares_display":"1,937","price_per_share":2.58,"price_display":"2.58","price_state":"stated","total_value":4997.46,"total_display":"4,997.46","total_whole":"4,997","shares_owned_after":591510.0,"shares_owned_after_display":"591,510","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-16","scope":"insider"},{"id":2370553,"accession":"0001415889-24-019546","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-019546","line_url":"/filing/0001415889-24-019546#line-2","is_derivative":false,"issuer_cik":"0001810182","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001810182","owner_cik":"0001816977","owner_name":"Pons Jaume","owner_display_name":"Pons Jaume","owner_url":"/insider/0001816977","role":"Director, Officer (PRESIDENT & CSO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":7.9038,"price_display":"7.90","price_state":"stated","total_value":158076.0,"total_display":"158,076.00","total_whole":"158,076","shares_owned_after":593447.0,"shares_owned_after_display":"593,447","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-11","filed_date":"2024-07-15","scope":"insider"},{"id":3177486,"accession":"0001415889-24-019221","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-019221","line_url":"/filing/0001415889-24-019221#line-1","is_derivative":false,"issuer_cik":"0001810182","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001810182","owner_cik":"0001816977","owner_name":"Pons Jaume","owner_display_name":"Pons Jaume","owner_url":"/insider/0001816977","role":"Director, Officer (PRESIDENT & CSO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10758.0,"shares_display":"10,758","price_per_share":5.8188,"price_display":"5.82","price_state":"stated","total_value":62598.6504,"total_display":"62,598.65","total_whole":"62,599","shares_owned_after":593447.0,"shares_owned_after_display":"593,447","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-01","filed_date":"2024-07-03","scope":"insider"},{"id":2806540,"accession":"0001415889-24-015737","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-015737","line_url":"/filing/0001415889-24-015737#line-2","is_derivative":false,"issuer_cik":"0001810182","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001810182","owner_cik":"0001816977","owner_name":"Pons Jaume","owner_display_name":"Pons Jaume","owner_url":"/insider/0001816977","role":"Director, Officer (PRESIDENT & CSO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":8.4326,"price_display":"8.43","price_state":"stated","total_value":168652.0,"total_display":"168,652.00","total_whole":"168,652","shares_owned_after":604205.0,"shares_owned_after_display":"604,205","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-04","filed_date":"2024-06-06","scope":"insider"},{"id":2069643,"accession":"0001415889-24-012637","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-012637","line_url":"/filing/0001415889-24-012637#line-2","is_derivative":false,"issuer_cik":"0001810182","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001810182","owner_cik":"0001816977","owner_name":"Pons Jaume","owner_display_name":"Pons Jaume","owner_url":"/insider/0001816977","role":"Director, Officer (PRESIDENT & CSO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":15.9167,"price_display":"15.92","price_state":"stated","total_value":318334.0,"total_display":"318,334.00","total_whole":"318,334","shares_owned_after":604205.0,"shares_owned_after_display":"604,205","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-06","filed_date":"2024-05-08","scope":"insider"},{"id":2601954,"accession":"0001415889-24-011128","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-011128","line_url":"/filing/0001415889-24-011128#line-2","is_derivative":false,"issuer_cik":"0001810182","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001810182","owner_cik":"0001816977","owner_name":"Pons Jaume","owner_display_name":"Pons Jaume","owner_url":"/insider/0001816977","role":"Director, Officer (PRESIDENT & CSO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":14.2039,"price_display":"14.20","price_state":"stated","total_value":710195.0,"total_display":"710,195.00","total_whole":"710,195","shares_owned_after":604205.0,"shares_owned_after_display":"604,205","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-16","filed_date":"2024-04-18","scope":"insider"},{"id":2100990,"accession":"0001415889-24-010443","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-010443","line_url":"/filing/0001415889-24-010443#line-1","is_derivative":false,"issuer_cik":"0001810182","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001810182","owner_cik":"0001816977","owner_name":"Pons Jaume","owner_display_name":"Pons Jaume","owner_url":"/insider/0001816977","role":"Director, Officer (PRESIDENT & CSO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":11.1518,"price_display":"11.15","price_state":"stated","total_value":223036.0,"total_display":"223,036.00","total_whole":"223,036","shares_owned_after":628359.0,"shares_owned_after_display":"628,359","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-04","filed_date":"2024-04-05","scope":"insider"},{"id":3170171,"accession":"0001209191-24-000359","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-24-000359","line_url":"/filing/0001209191-24-000359#line-1","is_derivative":false,"issuer_cik":"0001810182","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001810182","owner_cik":"0001816977","owner_name":"Pons Jaume","owner_display_name":"Pons Jaume","owner_url":"/insider/0001816977","role":"Director, Officer (President & CSO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7179.0,"shares_display":"7,179","price_per_share":15.04,"price_display":"15.04","price_state":"stated","total_value":107972.16,"total_display":"107,972.16","total_whole":"107,972","shares_owned_after":618359.0,"shares_owned_after_display":"618,359","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-29","filed_date":"2024-01-03","scope":"insider"},{"id":8372566,"accession":"0001209191-23-041197","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-041197","line_url":"/filing/0001209191-23-041197#line-1","is_derivative":false,"issuer_cik":"0001810182","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001810182","owner_cik":"0001816977","owner_name":"Pons Jaume","owner_display_name":"Pons Jaume","owner_url":"/insider/0001816977","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3208.0,"shares_display":"3,208","price_per_share":7.34,"price_display":"7.34","price_state":"stated","total_value":23546.72,"total_display":"23,546.72","total_whole":"23,547","shares_owned_after":536538.0,"shares_owned_after_display":"536,538","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-30","filed_date":"2023-07-05","scope":"insider"},{"id":8650946,"accession":"0001209191-23-000472","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-000472","line_url":"/filing/0001209191-23-000472#line-1","is_derivative":false,"issuer_cik":"0001810182","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001810182","owner_cik":"0001816977","owner_name":"Pons Jaume","owner_display_name":"Pons Jaume","owner_url":"/insider/0001816977","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3232.0,"shares_display":"3,232","price_per_share":11.0701,"price_display":"11.07","price_state":"stated","total_value":35778.5632,"total_display":"35,778.56","total_whole":"35,779","shares_owned_after":539746.0,"shares_owned_after_display":"539,746","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-29","filed_date":"2023-01-03","scope":"insider"},{"id":5055051,"accession":"0001209191-21-061195","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-061195","line_url":"/filing/0001209191-21-061195","is_derivative":false,"issuer_cik":"0001810182","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001810182","owner_cik":"0001816977","owner_name":"Pons Jaume","owner_display_name":"Pons Jaume","owner_url":"/insider/0001816977","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16700.0,"shares_display":"16,700","price_per_share":54.29426676646707,"price_display":"54.29","price_state":"stated","total_value":906714.255,"total_display":"906,714.26","total_whole":"906,714","shares_owned_after":446827.0,"shares_owned_after_display":"446,827","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-19","filed_date":"2021-10-20","scope":"insider","n_lines":2},{"id":4903149,"accession":"0001209191-21-061198","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-061198","line_url":"/filing/0001209191-21-061198","is_derivative":false,"issuer_cik":"0001810182","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001810182","owner_cik":"0001816977","owner_name":"Pons Jaume","owner_display_name":"Pons Jaume","owner_url":"/insider/0001816977","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16700.0,"shares_display":"16,700","price_per_share":54.29426676646707,"price_display":"54.29","price_state":"stated","total_value":906714.255,"total_display":"906,714.26","total_whole":"906,714","shares_owned_after":446827.0,"shares_owned_after_display":"446,827","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-19","filed_date":"2021-10-20","scope":"insider","n_lines":2},{"id":4236408,"accession":"0001209191-21-057033","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-057033","line_url":"/filing/0001209191-21-057033","is_derivative":false,"issuer_cik":"0001810182","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001810182","owner_cik":"0001816977","owner_name":"Pons Jaume","owner_display_name":"Pons Jaume","owner_url":"/insider/0001816977","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16700.0,"shares_display":"16,700","price_per_share":74.38398835928143,"price_display":"74.38","price_state":"stated","total_value":1242212.6056,"total_display":"1,242,212.61","total_whole":"1,242,213","shares_owned_after":463247.0,"shares_owned_after_display":"463,247","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-20","filed_date":"2021-09-21","scope":"insider","n_lines":4},{"id":5163974,"accession":"0001209191-21-052864","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-21-052864","line_url":"/filing/0001209191-21-052864","is_derivative":false,"issuer_cik":"0001810182","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001810182","owner_cik":"0001816977","owner_name":"Pons Jaume","owner_display_name":"Pons Jaume","owner_url":"/insider/0001816977","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16700.0,"shares_display":"16,700","price_per_share":61.27787161077844,"price_display":"61.28","price_state":"stated","total_value":1023340.4559,"total_display":"1,023,340.46","total_whole":"1,023,340","shares_owned_after":487065.0,"shares_owned_after_display":"487,065","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-19","filed_date":"2021-08-20","scope":"insider","n_lines":7},{"id":5498770,"accession":"0001209191-21-047365","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-047365","line_url":"/filing/0001209191-21-047365","is_derivative":false,"issuer_cik":"0001810182","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001810182","owner_cik":"0001816977","owner_name":"Pons Jaume","owner_display_name":"Pons Jaume","owner_url":"/insider/0001816977","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16700.0,"shares_display":"16,700","price_per_share":54.56556946107784,"price_display":"54.57","price_state":"stated","total_value":911245.01,"total_display":"911,245.01","total_whole":"911,245","shares_owned_after":500446.0,"shares_owned_after_display":"500,446","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-19","filed_date":"2021-07-20","scope":"insider","n_lines":3},{"id":4838019,"accession":"0001209191-21-042395","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-042395","line_url":"/filing/0001209191-21-042395","is_derivative":false,"issuer_cik":"0001810182","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001810182","owner_cik":"0001816977","owner_name":"Pons Jaume","owner_display_name":"Pons Jaume","owner_url":"/insider/0001816977","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16700.0,"shares_display":"16,700","price_per_share":58.59163261077844,"price_display":"58.59","price_state":"stated","total_value":978480.2646,"total_display":"978,480.26","total_whole":"978,480","shares_owned_after":511246.0,"shares_owned_after_display":"511,246","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-21","filed_date":"2021-06-22","scope":"insider","n_lines":2},{"id":5529023,"accession":"0001209191-21-034662","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-034662","line_url":"/filing/0001209191-21-034662","is_derivative":false,"issuer_cik":"0001810182","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001810182","owner_cik":"0001816977","owner_name":"Pons Jaume","owner_display_name":"Pons Jaume","owner_url":"/insider/0001816977","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16700.0,"shares_display":"16,700","price_per_share":55.70514962275449,"price_display":"55.71","price_state":"stated","total_value":930275.9987,"total_display":"930,276.00","total_whole":"930,276","shares_owned_after":528925.0,"shares_owned_after_display":"528,925","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-19","filed_date":"2021-05-20","scope":"insider","n_lines":3},{"id":5187808,"accession":"0000899243-21-016591","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-21-016591","line_url":"/filing/0000899243-21-016591","is_derivative":false,"issuer_cik":"0001810182","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001810182","owner_cik":"0001816977","owner_name":"Pons Jaume","owner_display_name":"Pons Jaume","owner_url":"/insider/0001816977","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16700.0,"shares_display":"16,700","price_per_share":57.630741826347304,"price_display":"57.63","price_state":"stated","total_value":962433.3885,"total_display":"962,433.39","total_whole":"962,433","shares_owned_after":549060.0,"shares_owned_after_display":"549,060","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-19","filed_date":"2021-04-21","scope":"insider","n_lines":5},{"id":4973926,"accession":"0000899243-21-013283","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-21-013283","line_url":"/filing/0000899243-21-013283","is_derivative":false,"issuer_cik":"0001810182","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001810182","owner_cik":"0001816977","owner_name":"Pons Jaume","owner_display_name":"Pons Jaume","owner_url":"/insider/0001816977","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16700.0,"shares_display":"16,700","price_per_share":68.49464011976048,"price_display":"68.49","price_state":"stated","total_value":1143860.49,"total_display":"1,143,860.49","total_whole":"1,143,860","shares_owned_after":551946.0,"shares_owned_after_display":"551,946","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-22","filed_date":"2021-03-24","scope":"insider","n_lines":7}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":47,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":47,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":47},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001810182","name":"ALX ONCOLOGY HOLDINGS INC","url":"/issuer/0001810182","role":"Director, Officer (PRESIDENT & CSO)","n_filings":21,"first_seen":"2021-03-24","last_seen":"2025-02-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001816977","retrieved_at":"2026-08-27T16:49:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}